Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017106

CHAIRMAN AND CEO acquired 259,302 shares (grant or award)

  • CHAIRMAN AND CEO acquired 93,976,905 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Trieu Vuong · CHAIRMAN AND CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 1 in the form +74,455,719 90,268,021 D
2021-07-08 Grant or award : show line 2 in the form +259,302 90,527,323 D
2021-03-31 Conversion : show line 3 in the form +13,849,161 16,780,384 I
2021-03-31 Conversion : show line 4 in the form +5,672,025 6,872,529 I

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 5 in the form Series A Convertible Preferred Stock −74,456 0 D
2021-03-31 Conversion : show line 6 in the form Series A Convertible Preferred Stock −13,849 0 I
2021-03-31 Conversion : show line 7 in the form Series A Convertible Preferred Stock −5,672 0 I
2021-07-08 Grant or award : show line 8 in the form Stock Options +513,953 513,953 D
Loading xslF345X03/ownership.xml…